Jenkoo retweeted
BREAKING NEWS; The Petition calling for Another GENERAL ELECTION due to the Mistruths ok Lies told by @Keir_Starmer & @RachelReevesMP who have BREACHED their promises has surpassed>10,000 mark NOW? 100,000👇
Call a General Election - Petitions petition.parliament.uk/petit…
Jenkoo retweeted
Great to see so much interest in the poster presentations of our two novel preCISION programs at #ENASymp24! #AVCT
Jenkoo retweeted
Good chance #AVCT ‘s CC & NED DD-H have been sounding out US investors for a NASDAQ list raise.
CC’s ‘I know them’ comment wrt US
II’s, DD-H’s deep capital markets experience & the company openly discussing the goal of listing, clearly makes this a plausible scenario.
Jenkoo retweeted
#AVCT
Enhertu barely scratching the surface, in solid tumour treatment at least.
With 2023 revs of $2.556 Bn, x by 6 for a FAP targeted approach
= $15.336bn
+ conservative pharma multiple (6.2)
= $95.0832 bn
(Less a tonne of undesirable SE’s)
The opportunity is monstrous!
Jenkoo retweeted
#AIM would certainly put cat amongst the pigeons!! Perhaps a wake up call to the huge lag in values here…
NEW TYPE OF WEAPON TO DELIVER CHEMO PRECISELY ON TARGET: @AACR @avacta revealed the very first results from a new way to attack cancer. Imagine chemo only hitting tumors+not ALL your cells,that's the idea here.Definitely one to watch! avacta.com/avacta-therapeuti…
Jenkoo retweeted
A reminder that in 2015 Ketruda posted a 75% disease control rate on 1 specially selected indication in order to increase chances of positive results. #AVCT just posted 67% which included numerous tumours known to not be responsive to dox.
Jenkoo retweeted
Replying to @LittleGunner5 @tom_the_bomb__
The ones who understand the tech would be devastated if an offer of say £6 was offered to the market and accepted due to lack of funds who do understand to be able to block it.
#AVCT
2/2
Jenkoo retweeted
My thoughts following the #GBP interview.. unicorn.
Very good interview by new bod member Daniel. Touched on the recent joint venture... Opportunities of a Producing asset is very significant and excited to pursue that...! Hopefully we get some big new soon of a producing asset funded via the JV 🤑 it will multibag off that #GBP
Jenkoo retweeted
#gbp
Now for those who are wondering how strong this partnership with cynergy are then look at the key members are of each board and you’ll realise the scale level #gbp is working with
Cynergy
💥Mike germanos - founder and highly connected in the $oil space including gulf sovereign wealth funds aka royal families
💥Richard Luddington - senior advisor to Rothschild, clients are governments and institutions
💥Nick Cochrane-Dyet - senior advisor to BP Chief Representative in Abu Dhabi and chairs the Middle East Advisory Board of the Energy Industry Council
💥Sir Graham Hugh Boyce - former advisor to Lehman brothers in Middle East, now current advisor to Namora. Former diplomat
💥Yaacov Amidror - former security adviser to government
#gbp
💥Daniel page - former head of asset management kpmg
💥Cecilia Yu - credit trader and founder of billion dollar hedge fund
💥Azib khan - actuary and equities research
This is a mega team forming here
✅ political connections
✅sovereign wealth fund connections, ✅senior advisors to TIER 1 $oil and gas companies
✅connections to Middle East $oil and gas
✅News Articles showing cynergy looking at multi billion dollar projects
✅Daniel and Cecilia expertise and connections using #gbp imo to be part of this
Something really incredible is being here and now I think Daniel page was being prudent when saying 250m market cap
Jenkoo retweeted
BBIO, $7Bn, Rev? $9.4m
RETA, $7.3Bn, Rev? $22m
GRCL, $1.2Bn, Rev? Nil
CBAY, $2.7Bn, Rev? $30m
AUTL, $1.12Bn, Rev? $406k
NUVL, $4.61Bn, Rev? Nil
#AVCT, £330m, Rev? £20m+
If #AVCT is on your watchlist for 2024, check the US biotech darlings of 2023, then check their rev.
GRCL really stands out for me. A basket of INDs for £950m.
AVCT could put itself up for sale and sell for more, if it downed every tool tomorrow.
All the best for 24.
Jenkoo retweeted
Watch a killer T cell of the immune system destroying a monstrous ovarian cancer cell.
[📹 Alex Ritter]
xitter.gq/RKian_Service/status/1…
Jenkoo retweeted
Head of program innovation, Global Drug Development at Novartis also believes #AVCT could be realising a paradigm shift in cancer treatment with pre|CISION
Things going to get real interesting real soon with this stock. This is the big one guys. This is it.
Jenkoo retweeted
Last time I heard of paradigm change/shift in biotech, it was for MRNA technology... Whats that valued at?!
Now you see the potential realising itself. Billions.
#avct
Jenkoo retweeted
...almost 200 life science companies. We have access to a huge talent pool from Imperial College and several other London Universities, and have completed a recruitment round to ensure we have access to cutting edge drug discovery in our labs.”












































